Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Artificial organs Stories

2012-02-27 14:28:00

NEW YORK, Feb. 27, 2012 /PRNewswire/ -- JARVIK HEART, Inc., a privately-held company that develops and manufactures cardiac assist devices, announced conditional FDA approval of its Pivotal Trial for evaluation of the Jarvik 2000® heart for destination therapy (DT). Use of the device for DT means that it will provide long-term, permanent support to end-stage congestive heart failure patients who are not candidates for heart transplant. The approval permits fifty medical centers to...

2012-02-23 07:05:00

TUCSON, Ariz., Feb. 23, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the 1,000th implant of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart was performed on Feb. 10 at The University of Arizona Medical Center in Tucson, AZ. Since then, an additional four implants of the Total Artificial Heart have been performed at SynCardia Certified Centers...

2012-02-14 09:00:00

PLEASANTON, Calif., Feb. 14, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16. Taylor C. Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company, beginning at 4:00 p.m., Eastern Standard...

2012-01-04 21:00:00

SynCardia Profitable for 1st Time in Company´s 10-Year History Tucson, AZ (PRWEB) January 04, 2012 SynCardia Systems, Inc., manufacturer of the world´s only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009. “This is the first full year that SynCardia has been profitable during the company´s 10-year history,”...

2012-01-04 11:51:00

TUCSON, Ariz., Jan. 4, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009. (Photo: http://photos.prnewswire.com/prnh/20120104/LA29865) "This is the first full year that SynCardia has been profitable during the company's...

FDA Approves First Heart Pump For Children Awaiting Transplant
2011-12-19 06:30:26

The U.S. Food and Drug Administration (FDA) said on Friday that it has approved the first heart pump for children with heart failure, giving a new treatment option for patients who are too small to receive adult implants. The ventricular assist device is made by Germany-based Berlin Heart, and is the first heart pump approved to help children survive as they await a heart transplant.   The device does the work of a normal heart in children with congenital or other cardiovascular...

2011-12-09 10:00:00

PLEASANTON, Calif., Dec. 9, 2011 /PRNewswire/ -- Thoratec (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Oppenheimer & Co. 22nd Annual Healthcare Conference on Tuesday, December 13. Taylor C. Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company, beginning at 10:15 a.m., Eastern Standard Time...

2011-12-08 14:35:00

List Features 100 Privately-Held Companies with Compelling Business Models, Strong, Management Teams, Investment Capital and Notable Customers Tucson, Ariz. (PRWEB) December 08, 2011 SynCardia Systems, Inc., the privately-held manufacturer of the worldâs only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of âœAmericaâs Most Promising Companies.â The list features 100...

2011-12-01 15:16:00

In the news release, Waterproof Neptune Sound Processor From Advanced Bionics Approved in United States and Canada, issued 01-Dec-2011 by Advanced Bionics over PR Newswire, the disclaimer paragraph should read "*Neptune is pending regulatory approval in markets outside of the United States and Canada. ClearVoice is pending regulatory approval in the United States. HiRes Fidelity 120 is not approved for pediatric use in the United States" rather than "*Neptune is pending regulatory approval in...

2011-12-01 11:00:00

VALENCIA, Calif., Dec. 1, 2011 /PRNewswire/ -- Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in the United States and Canada for Neptune(TM)*, the world's first and only swimmable, waterproof sound processor. Intended for swimming and bathing, Neptune is designed to help cochlear implant recipients hear in and out of the water. Recipients using other products on the market remove their processor when they...